SEC Form 4 · accession 0001209191-16-094247
aTYR PHARMA INC · LIFE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul Schimmel
Director
Period of report
Jan 27, 2016
Accepted (ET)
Jan 29, 2016 · 6:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001339970
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 16, 2015 | G | 11,925 | $0.00 | D | 634,242 | I | See Footnote |
| Common Stock | holding | — | — | — | 12,572 | D | ||
| Common StockF2 | holding | — | — | — | 31,181 | I | See Footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3 | $6.14 | Jan 27, 2016 | A | 19,428 | A | — | Jan 27, 2026 | Common Stock | 19,428 | 19,428 | D |
Explanation of responses
- F1These shares are owned directly by Schimmel Revocable Trust U/A Dtd 9/6/2000. The Reporting Person is the sole trustee of the Schimmel Revocable Trust U/A Dtd 9/6/2000.
- F2These shares are owned directly by Paul R. Schimmel Prototype PSP. The Reporting Person is the sole owner of the Paul R. Schimmel Prototype PSP.
- F3The shares subject to this option shall vest and become exercisable in 36 equal monthly installments beginning on February 27, 2016, such that this option will be fully exercisable on January 27, 2019.